Bacteroides vesicles promote functional alterations in the gut microbiota composition

被引:3
|
作者
Shagaleeva, Olga Yu. [1 ]
Kashatnikova, Daria A. [1 ,2 ]
Kardonsky, Dmitry A. [1 ]
Efimov, Boris A. [1 ,3 ]
Ivanov, Viktor A. [1 ]
Smirnova, Svetlana V. [2 ]
Evsiev, Suleiman S. [1 ]
Zubkov, Eugene A. [4 ]
Abramova, Olga V. [4 ]
Zorkina, Yana A. [4 ]
Morozova, Anna Y. [4 ]
Vorobeva, Elizaveta A. [1 ]
Silantiev, Artemiy S. [1 ]
Kolesnikova, Irina V. [1 ]
Markelova, Maria I. [5 ]
Olekhnovich, Evgenii I. [1 ]
Morozov, Maxim D. [1 ]
Zoruk, Polina Y. [1 ]
Boldyreva, Daria I. [1 ]
Kazakova, Victoriia D. [1 ]
Vanyushkina, Anna A. [6 ]
Chaplin, Andrei V. [1 ,3 ]
Grigoryeva, Tatiana V. [5 ]
Zakharzhevskaya, Natalya B. [1 ]
机构
[1] Phys Chem Med Fed Med Biol Agcy, Lopukhin Fed Res & Clin Ctr, Moscow, Russia
[2] Russian Acad Sci, Vavilov Inst Gen Genet, Lab Ecol Genet, Moscow, Russia
[3] Pirogov Russian Natl Res Med Univ, Dept Microbiol & Virol, Moscow, Russia
[4] VP Serbsky Natl Med Res Ctr Psychiat & Narcol, Dept Basic & Appl Neurobiol, Moscow, Russia
[5] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia
[6] Skolkovo Inst Sci & Technol, Vladimir Zelman Ctr Neurobiol & Brain Rehabil, Moscow, Russia
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
俄罗斯科学基金会;
关键词
HS-GC/MS; IBD; OMVs; DSS-induced colitis; MURINE MODEL; COLITIS; DISEASE; MANAGEMENT;
D O I
10.1128/spectrum.00636-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Inflammatory bowel diseases are characterized by chronic intestinal inflammation and alterations in the gut microbiota composition. Bacteroides fragilis, which secretes outer membrane vesicles (OMVs) with polysaccharide A (PSA), can moderate the inflammatory response and possibly alter the microbiota composition. In this study, we created a murine model of chronic sodium dextran sulfate (DSS)-induced intestinal colitis and treated it with B. fragilis OMVs. We monitored the efficiency of OMV therapy by determining the disease activity index (DAI) and performing histological examination (HE) of the intestine before and after vesicle exposure. We also analyzed the microbiota composition using 16S rRNA gene sequencing. Finally, we evaluated the volatile compound composition in the animals' stools by HS-GC/MS to assess the functional activity of the microbiota. We observed more effective intestinal repair after OMV treatment according to the DAI and HE. A metabolomic study also revealed changes in the functional activity of the microbiota, with a predominance of phenol and pentanoic acid in the control group compared to the group treated with DSS and the group treated with OMVs (DSS OMVs). We also observed a positive correlation of these metabolites with Saccharibacteria and Acetivibrio in the control group, whereas in the DSS group, there was a negative correlation of phenol and pentanoic acid with Lactococcus and Romboutsia. According to the metabolome and sequencing data, the microbiota composition of the DSS-treated OMV group was intermediate between that of the control and DSS groups. OMVs not only have an anti-inflammatory effect but also contribute to the recovery of the microbiota composition.IMPORTANCEBacteroides fragilis vesicles contain superficially localized polysaccharide A (PSA), which has unique immune-modulating properties. Isolated PSA can prevent chemically induced colitis in a murine model. Outer membrane vesicles (OMVs) also contain digestive enzymes and volatile metabolites that can complement the anti-inflammatory properties of PSA. OMVs showed high therapeutic activity against sodium dextran sulfate-induced colitis, as confirmed by histological assays. 16S rRNA sequencing of fecal samples from different inflammatory stages, supplemented with comprehensive metabolome analysis of volatile compounds conducted by HS-GC/MS, revealed structural and functional alterations in the microbiota composition under the influence of OMVs. Correlation analysis of the OMV-treated and untreated experimental animal groups revealed associations of phenol and pentanoic acid with Lactococcus, Romboutsia, Saccharibacteria, and Acetivibrio. Bacteroides fragilis vesicles contain superficially localized polysaccharide A (PSA), which has unique immune-modulating properties. Isolated PSA can prevent chemically induced colitis in a murine model. Outer membrane vesicles (OMVs) also contain digestive enzymes and volatile metabolites that can complement the anti-inflammatory properties of PSA. OMVs showed high therapeutic activity against sodium dextran sulfate-induced colitis, as confirmed by histological assays. 16S rRNA sequencing of fecal samples from different inflammatory stages, supplemented with comprehensive metabolome analysis of volatile compounds conducted by HS-GC/MS, revealed structural and functional alterations in the microbiota composition under the influence of OMVs. Correlation analysis of the OMV-treated and untreated experimental animal groups revealed associations of phenol and pentanoic acid with Lactococcus, Romboutsia, Saccharibacteria, and Acetivibrio.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration
    Notaristefano, Giovanna
    Ponziani, Francesca Romana
    Ranalli, Monia
    Diterlizzi, Alice
    Policriti, Martina Asia
    Stella, Leonardo
    Del Zompo, Fabio
    Fianchi, Francesca
    Picca, Anna
    Petito, Valentina
    Del Chierico, Federica
    Scanu, Matteo
    Toto, Francesca
    Putignani, Lorenza
    Marzetti, Emanuele
    Ferrarese, Daniele
    Mele, Maria Cristina
    Merola, Annamaria
    Tropea, Anna
    Gasbarrini, Antonio
    Scambia, Giovanni
    Lanzone, Antonio
    Apa, Rosanna
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2024, 326 (02): : E166 - E177
  • [42] Gut microbiota composition is associated with newborn functional brain connectivity and behavioral temperament
    Kelsey, Caroline M.
    Prescott, Stephanie
    McCulloch, John A.
    Trinchieri, Giorgio
    Valladares, Tara L.
    Dreisbach, Caitlin
    Alhusen, Jeanne
    Grossmann, Tobias
    BRAIN BEHAVIOR AND IMMUNITY, 2021, 91 : 472 - 486
  • [43] Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy
    Zhang, Lili
    Wang, Zhisheng
    Zhang, Xiaona
    Zhao, Lu
    Chu, Jinjin
    Li, Haibo
    Sun, Wenchang
    Yang, Chunjuan
    Wang, Hui
    Dai, Wenqing
    Yan, Shushan
    Chen, Xiaohua
    Xu, Donghua
    MICROBIOLOGY SPECTRUM, 2022, 10 (04):
  • [44] Alterations in Gut Microbiota and Immunity by Dietary Fat
    Yang, Bo-Gie
    Hur, Kyu Yeon
    Lee, Myung-Shik
    YONSEI MEDICAL JOURNAL, 2017, 58 (06) : 1083 - 1091
  • [45] Endometriosis induces gut microbiota alterations in mice
    Yuan, Ming
    Li, Dong
    Zhang, Zhe
    Sun, Huihui
    An, Min
    Wang, Guoyun
    HUMAN REPRODUCTION, 2018, 33 (04) : 607 - 616
  • [46] Characteristic alterations of gut microbiota in uncontrolled gout
    Ul-Haq, Asad
    Lee, Kyung-Ann
    Seo, Hoonhee
    Kim, Sukyung
    Jo, Sujin
    Ko, Kyung Min
    Moon, Su-Jin
    Kim, Yun Sung
    Choi, Jung Ran
    Song, Ho-Yeon
    Kim, Hyun-Sook
    JOURNAL OF MICROBIOLOGY, 2022, 60 (12) : 1178 - 1190
  • [47] Alterations of the gut microbiota in borderline personality disorder
    Rossler, Hannah
    Flasbeck, Vera
    Gatermann, Soren
    Bruene, Martin
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2022, 158
  • [48] Characteristic alterations of gut microbiota in uncontrolled gout
    Asad ul-Haq
    Kyung-Ann Lee
    Hoonhee Seo
    Sukyung Kim
    Sujin Jo
    Kyung Min Ko
    Su-Jin Moon
    Yun Sung Kim
    Jung Ran Choi
    Ho-Yeon Song
    Hyun-Sook Kim
    Journal of Microbiology, 2022, 60 : 1178 - 1190
  • [49] Gut Microbiota Alterations in Patients With Kawasaki Disease
    Jena, Prasant K.
    Arditi, Moshe
    Rivas, Magali Noval
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2025, 45 (03) : 345 - 358
  • [50] Major Lipids, Apolipoproteins, and Alterations of Gut Microbiota
    Yun, Kyung Eun
    Kim, Jimin
    Kim, Mi-hyun
    Park, Eunkyo
    Kim, Hyung-Lae
    Chang, Yoosoo
    Ryu, Seungho
    Kim, Han-Na
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)